Back to HRTX

MARSHALL WACE, LLP → HRTX

MARSHALL WACE, LLP HRTX Position History

Heron Therapeutics, Inc. • Healthcare

Quarters held
15
Latest value
$109K
Q3 2026
Peak value
$6M
First seen
Q1 2024

Dollar value over time

Show data table
PeriodPosition value
Q1 2024$1.4M
Q2 2024$164K
Q2 2024$6M
Q3 2024$3.4M
Q4 2024$1.6M
Q1 2025$276K
Q1 2025$2.5M
Q2 2025$1M
Q2 2025$4.9M
Q3 2025$72K
Q3 2025$1.6M
Q2 2026$105K
Q2 2026$907K
Q3 2026$1K
Q3 2026$109K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$109K352.7K——
Q3 2026$1K4.8K——
Q2 2026$907K2.11M——
Q2 2026$105K244.6K——
Q3 2025$1.6M1.25M——
Q3 2025$72K57.5K——
Q2 2025$4.9M2.39M——
Q2 2025$1M506.4K——
Q1 2025$2.5M1.13M——
Q1 2025$276K125.3K——
Q4 2024$1.6M1.02M——
Q3 2024$3.4M1.72M——
Q2 2024$6M1.71M——
Q2 2024$164K46.7K——
Q1 2024$1.4M494.4K——

Other funds holding HRTX

Other MARSHALL WACE, LLP positions

ETHA

ISHARES-S&P 500

$17B
IAU

ISHARES-S&P 500

$12B
ETHA

ISHARES-S&P 500

$11.5B
IAU

ISHARES-S&P 500

$11.1B
IAU

ISHARES-S&P 500

$10.7B
IAU

ISHARES-S&P 500

$10.3B
IAU

ISHARES-S&P 500

$9.9B
ETHA

ISHARES-S&P 500

$8.4B